Dendritic Cells Archive - Seite 52 von 107 - IOZK

A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.

2014-07-31/in Dendritic Cells, Hypernephroma, International Publications /von 2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised „proof-of-principle“ phase II study

2014-07-22/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-22 / J Transl Med 2014 Jul;12:209

Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients

2014-07-17/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-47

Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells

2014-07-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-01 / Immunology 2014 Jul;142(3):396-405

Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells

2014-07-01/in Dendritic Cells, Hyperthermia, International Publications, Pancreatic Cancer /von 2014-07-01 / Yonsei Med. J. 2014 Jul;55(4):1014-27

Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial

2014-06-30/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-30 / Cell. Mol. Immunol. 2015 Jan;12(1):87-95

Ovarian cancer biology and immunotherapy

2014-06-09/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-09 / Int. Rev. Immunol. 2014 Oct;33(5):428-40

Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).

2014-06-01/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3069)

A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.

2014-06-01/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2005)

Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).

2014-06-01/in Dendritic Cells, Hypernephroma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3085)